The majority of drugs that enter the market are discovered by screening millions of random chemical compounds until a desired effect is achieved. With the recent explosion in available biological data and raw computing power, it is now possible to develop drugs through bottom-up design rather than trial-and-error testing. Bottom-up drug design has the potential […]

Current cancer therapies rely on toxic chemotherapeutic agents that lack the potency and selectivity of protein-based therapy. Consequently, new technologies to systematically target cancer signaling pathways at the protein level are urgently needed. Dr. Zhang has developed a platform that consistently and successfully produces quick and cost-effective protein-based therapies that are both highly-binding and specific […]